{"nct_id":"NCT05369403","title":"A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab","status":"COMPLETED","status_verified_date":"2025-03","start_date":"2022-12-19","start_date_type":"ACTUAL","primary_completion_date":"2024-01-11","primary_completion_date_type":"ACTUAL","completion_date":"2025-02-05","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["LLY"]}